Clinical Impact of Revised Ciprofloxacin Breakpoint in Patients with Urinary Tract Infections by Enterobacteriaceae.

Park GE, Ko JH, Cho SY, Huh HJ, Baek JY, Ko KS, Kang CI, Chung DR, Peck KR

DOI: 10.3390/antibiotics10040469
Published: 2021 Apr 20
Container: Antibiotics (Basel, Switzerland)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/antibiotics10040469,
  title = {Clinical Impact of Revised Ciprofloxacin Breakpoint in Patients with Urinary Tract Infections by Enterobacteriaceae.},
  author = {Park GE and Ko JH and Cho SY and Huh HJ and Baek JY and Ko KS and Kang CI and Chung DR and Peck KR},
  year = {2021},
  journal = {Antibiotics (Basel, Switzerland)},
  doi = {10.3390/antibiotics10040469},
  url = {https://doi.org/10.3390/antibiotics10040469}
}

RIS

TY  - JOUR
TI  - Clinical Impact of Revised Ciprofloxacin Breakpoint in Patients with Urinary Tract Infections by Enterobacteriaceae.
AU  - Park GE
AU  - Ko JH
AU  - Cho SY
AU  - Huh HJ
AU  - Baek JY
AU  - Ko KS
AU  - Kang CI
AU  - Chung DR
AU  - Peck KR
PY  - 2021
JO  - Antibiotics (Basel, Switzerland)
DO  - 10.3390/antibiotics10040469
UR  - https://doi.org/10.3390/antibiotics10040469
ER  -

APA

GE, P., JH, K., SY, C., HJ, H., JY, B., KS, K., CI, K., DR, C., & KR, P. (2021). Clinical Impact of Revised Ciprofloxacin Breakpoint in Patients with Urinary Tract Infections by Enterobacteriaceae.. Antibiotics (Basel, Switzerland). https://doi.org/10.3390/antibiotics10040469

Source records

pubmed · retrieved 2026-09-26T14:28:54.862Z